Autonomic paraneoplastic neurological syndromes

Autoimmunity Reviews

Volumn 6, Issue 3, 2007, Pages 162-168

  Lorusso, Lorenzo ^a   Hart, Ian K ^b   Ferrari, Daniela ^a   Ngonga, Gaelle K ^a   Gasparetto, Chiara ^c   Ricevuti, Giovanni ^c  

^a Mellino Mellini Hospital Trust   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autoimmune pathogenesis; Autonomic paraneoplastic neurological syndromes; Autonomic PNS; Onconeural antibody

Indexed keywords

ANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; STEROID;

AUTOIMMUNITY; CLINICAL FEATURE; HUMAN; IMMUNOLOGY; ONCOLOGY; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; REVIEW;

AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HUMANS; MODELS, IMMUNOLOGICAL; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

EID: 33846781763     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.10.003     Document Type: Review

References (31)

1. Darnell R.B. Paraneoplastic neurological disorders: windows into neuronal function and tumor immunity. Arch Neurol 61 (2004) 30-32
2. www.Emedecine.com/neuro/topic298.htm. Paraneoplastic autonomic syndrome.
3. Kashyap V., Panganamamula H., and Parkman P. Chronic intestinal pseudo-obstruction. Curr Treat Options Gastroenterol 8 (2005) 3-11
4. Camdessanche J.P., Antoine J.C., Honnorat J., Vial C., Petiot P., Convers P., et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 125 (2002) 166-175
5. Roberts W.K., and Darnell R.B. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 16 (2004) 616-622
6. Rosenblum M.K. Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome. Brain Pathol 3 (1993) 199-212
7. Freeman R. Autonomic peripheral neuropathy. Lancet 365 (2005) 1259-1270
8. Dalmau J. Paraneoplastic immune-mediated disorders of the nervous system. Continuum 7 (2001) 94-118
9. Lucchinetti C.F., Kimmel D.W., and Lennon V.A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50 (1998) 652-657
10. Yu Z., Kryzer T.J., Griesmann G.E., Kim K., Benarroch E.E., and Lennon V.A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49 (2001) 146-154
11. Antoine J.C., Honnorat J., Camdessanche J.P., Magistris M., Absi L., Mosnier J.F., et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 49 (2001) 214-221
12. Honnorat J., and Cartalat-Carel S. Advances in paraneoplastic neurological syndromes. Curr Opin Oncol 16 (2004) 614-620
13. Motomura M., Lang B., Johnson I., Palace J., Vincent A., and Newsom-Davis J. Incidence of serum anti P/Q and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 20 147 (1997) 35-42
14. O'Suilleabhain P., Low P.A., and Lennon V.A. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology 50 (1998) 88-93
15. Dropcho E.J. Neurologic paraneoplastic syndromes. Curr Oncol Rep 6 (2004) 26-31
16. Waterman S.A., Lang B., and Newsom-Davis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 42 (1997) 147-156
17. Vernino S., and Lennon V.A. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 47 (2000) 297-305
18. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., and Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343 (2000) 847-855
19. Vernino S., and Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10 (2004) 7270-7275
20. Vernino S., Cheshire W.P., and Lennon V.A. Myasthenia Gravis with autoimmune autonomic neuropathy. Auton Neurosci 88 (2001) 187-192
21. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., and Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4 (1998) 1321-1324
22. Casciola-Rosen L.A., Anhalt G., and Rosen A. Autoantigens targeted in systemic lupus erythemaosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179 (1994) 1317-1330
23. Hickey F. Leucocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 11 (1999) 125-137
24. Becher B., Prat A., and Antel J.P. Brain-immune connection: immunoregulatory properties of CNS-resident cells. Glia 29 (2000) 293-304
25. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., and Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 290 (2000) 2155-2159
26. Darnell R.B., and Posner J.B. Paraneoplastic syndromes involving the nervous system. N Engl J Med 349 (2003) 1543-1554
27. Greenlee J.E., Parks T.N., and Jaeckle K.A. Type IIa ("anti-Hu") antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology 43 (1993) 2049-2054
28. Christen U., and von Herrath M.G. Initiation of autoimmunity. Curr Opin Immunol 16 (2004) 759-767
29. Linke R., Schroeder M., Helmberger T., and Voltz R. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology 63 (2004) 282-286
30. Younes-Mhenni S., Janier M.F., Cinotti L., et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127 (2004) 2331-2338
31. Vedeler C.A., Antoine J.C., Giometto B., Graus F., Grisold W., Hart I.K., et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13 (2006) 682-690